DOT1L c.386A>G ;(p.E129G)

Variant ID: 19-2191132-A-G

NM_032482.2(DOT1L):c.386A>G;(p.E129G)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021-10-19

Variant appearance in text: DOT1L: E129G
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 6
View BVdb publication page



Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021

Variant appearance in text: DOT1L: E129G
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 6
View BVdb publication page